Deciding Which Cancer-Related Fatigue Assessment Tool to Use Just Got Much Easier.

Citation metadata

Author: Lisa Sprod
Date: May 2022
From: Oncology(Vol. 36, Issue 5)
Publisher: Intellisphere, LLC
Document Type: Article
Length: 610 words
Lexile Measure: 1530L

Document controls

Main content

Article Preview :

Cancer-related fatigue (CRF) is most often evaluated using patient-reported tools, making it subjective in nature. In addition, CRF is multidimensional and often a comorbid condition occurring with mood disorders, pain, and sleep disturbance, among others. Numerous tools have been developed to assess CRF, yet it remains the most common and persistent symptom and/or adverse effect resulting from cancer and its treatment, often lasting many years. In a large multicenter study (n > 3000), Wang et al found that moderate to severe fatigue is common in cancer survivors during active treatment and beyond. (1) Other investigators have found that up to 99% of patients with cancer report CRF; and in up to one-third of survivors, fatigue persisted for as long as 10 years after the end of therapy. (2)

Despite the high prevalence of CRF, it is still thought to be underreported and undertreated, perhaps in part due to confusion about how to...

Source Citation

Source Citation   

Gale Document Number: GALE|A704419378